Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 156.25 | 63.10 | 65.00 | 76.75 | 0.8469 | 0.1105 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 156.25 | 63.10 | 103.00 | 76.75 | 1.3420 | 4.6674 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 156.25 | 63.10 | 72.00 | 76.75 | 0.9381 | 0.5951 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 156.25 | 63.10 | 33.00 | 76.75 | 0.4300 | -0.8993 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 156.25 | 63.10 | 69.00 | 76.75 | 0.8990 | 0.3720 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 67.00 | 76.75 | 0.8730 | 0.2363 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 43.00 | 76.75 | 0.5603 | -0.7429 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 86.00 | 76.75 | 1.1205 | 1.9923 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 66.00 | 76.75 | 0.8599 | 0.1722 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 156.25 | 63.10 | 71.00 | 76.75 | 0.9251 | 0.5180 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 156.25 | 63.10 | 144.00 | 76.75 | 1.8762 | 17.5627 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 156.25 | 63.10 | 112.00 | 76.75 | 1.4593 | 6.6242 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 156.25 | 63.10 | 101.00 | 76.75 | 1.3160 | 4.2873 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 156.25 | 63.10 | 74.00 | 76.75 | 0.9642 | 0.7576 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 156.25 | 63.10 | 109.00 | 76.75 | 1.4202 | 5.9254 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 68.00 | 76.75 | 0.8860 | 0.3029 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 156.25 | 63.10 | 93.00 | 76.75 | 1.2117 | 2.9477 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 156.25 | 63.10 | 96.00 | 76.75 | 1.2508 | 3.4173 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 156.25 | 63.10 | 57.00 | 76.75 | 0.7427 | -0.3025 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 91.00 | 76.75 | 1.1857 | 2.6552 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 156.25 | 63.10 | 98.00 | 76.75 | 1.2769 | 3.7519 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 133.00 | 76.75 | 1.7329 | 13.0104 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 156.25 | 63.10 | 80.00 | 76.75 | 1.0423 | 1.3163 |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 156.25 | 63.10 | 100.00 | 76.75 | 1.3029 | 4.1042 |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 156.25 | 63.10 | 45.00 | 76.75 | 0.5863 | -0.6980 |